Format

Send to

Choose Destination
Lancet Infect Dis. 2015 Jan;15(1):15-6. doi: 10.1016/S1473-3099(14)71051-5.

TB-HAART trial--authors' reply.

Author information

1
National Institute for Medical Research (NIMR), Muhumbili Centre, Tanzania.
2
Department of Medicine, Makerere University College of Health Sciences, Mulago Hospital, Kampala, Uganda.
3
Institute for Medical Research & Training (IMReT), University Teaching Hospital, Lusaka, Zambia. Electronic address: duncan.chanda@gmail.com.
4
Clinical Trials Unit, Medical Research Council, Durban, South Africa.
5
Institute for Medical Research & Training (IMReT), University Teaching Hospital, Lusaka, Zambia.
6
Supra-National TB Laboratory, Ministry of Health, Kampala, Uganda.
7
University College London, and NIHR Biomedical research centre, University College Hospitals, London, United Kingdom.
PMID:
25541163
DOI:
10.1016/S1473-3099(14)71051-5
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center